Filana Therapeutics, Inc. (FLNA)

Filana Therapeutics Market Cap

Filana Therapeutics has a market cap or net worth of $83.57 million as of April 2, 2026. Its market cap has decreased by -36.40% in one year.

• Market Cap: 83.57M
• Enterprise Value: -11.93M
• 1-Year Change: -36.40%
• Ranking: #4300
• Category: Micro-Cap
• Stock Price: $1.73

Market Cap Chart

Since July 14, 2000, Filana Therapeutics's market cap has decreased from $565.10M to $83.57M, a decrease of -85.21%. That is a compound annual growth rate of -7.16%.

Market Cap History

Date	Market Cap	% Change
Apr 2, 2026	83.60M	-12.55%
Dec 31, 2025	95.60M	-15.77%
Dec 31, 2024	113.50M	-88.04%
Dec 29, 2023	949.30M	-19.80%
Dec 30, 2022	1.18B	-32.32%
Dec 31, 2021	1.75B	902.69%
Dec 31, 2020	174.40M	94.86%
Dec 31, 2019	89.50M	513.01%
Dec 31, 2018	14.60M	-44.70%
Dec 29, 2017	26.40M	0.38%
Dec 30, 2016	26.30M	-67.17%
Dec 31, 2015	80.10M	-13.78%
Dec 31, 2014	92.90M	-57.93%
Dec 31, 2013	220.80M	80.84%
Dec 31, 2012	122.10M	-28.01%
Dec 30, 2011	169.60M	-41.19%
Dec 31, 2010	288.40M	27.44%
Dec 31, 2009	226.30M	-8.97%
Dec 31, 2008	248.60M	-46.82%
Dec 31, 2007	467.50M	18.81%
Dec 29, 2006	393.50M	32.67%
Dec 30, 2005	296.60M	-5.66%
Dec 31, 2004	314.40M	28.01%
Dec 31, 2003	245.60M	277.85%
Dec 31, 2002	65.00M	-73.54%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Gossamer Bio	86.84M
Anixa Biosciences	85.50M
Kazia Therapeutics	83.87M
PolyPid	83.78M
Rani Therapeutics Holdings	83.75M
Pliant Therapeutics	83.58M
aTyr Pharma	83.04M
NeurAxis	81.11M